# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Feb 22, 2024

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2024-02-22
- Accepted by EDGAR: Feb 21, 2024, 17:42 ET
- Period: 2024-02-21
- Accession: 0001628280-24-005998
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000162828024005998/arwr-20240221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000162828024005998/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000162828024005998/arwr-20240221.htm

Filed Feb 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-005998. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.